Bank of America’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.7M Buy
1,216,843
+515,209
+73% +$28M 0.01% 1369
2025
Q4
$32.4M Buy
701,634
+66,564
+10% +$2.98M ﹤0.01% 1890
2025
Q3
$22.9M Sell
635,070
-447,601
-41% -$14.8M ﹤0.01% 2498
2025
Q2
$35.2M Buy
1,082,671
+291,859
+37% +$9.57M ﹤0.01% 2008
2025
Q1
$29.9M Buy
790,812
+320,901
+68% +$25.7M ﹤0.01% 2050
2024
Q4
$38.5M Sell
469,911
-99,979
-18% -$9.93M ﹤0.01% 1725
2024
Q3
$65.1M Buy
569,890
+98,609
+21% +$8.89M 0.01% 1349
2024
Q2
$35.6M Buy
471,281
+185,405
+65% +$12.6M ﹤0.01% 1728
2024
Q1
$19.5M Buy
285,876
+111,725
+64% +$7.74M ﹤0.01% 2309
2023
Q4
$10.9M Sell
174,151
-35,982
-17% -$1.87M ﹤0.01% 2791
2023
Q3
$10.7M Sell
210,133
-30,970
-13% -$1.53M ﹤0.01% 2652
2023
Q2
$12M Sell
241,103
-43,006
-15% -$2.04M ﹤0.01% 2530
2023
Q1
$10.6M Sell
284,109
-12,510
-4% -$531K ﹤0.01% 2759
2022
Q4
$14.2M Buy
296,619
+190,164
+179% +$7.46M ﹤0.01% 2335
2022
Q3
$2.56M Buy
106,455
+10,151
+11% +$257K ﹤0.01% 4055
2022
Q2
$2.1M Buy
96,304
+57,826
+150% +$1.34M ﹤0.01% 4259
2022
Q1
$929K Sell
38,478
-36,589
-49% -$799K ﹤0.01% 5346
2021
Q4
$1.78M Buy
75,067
+46,834
+166% +$1.09M ﹤0.01% 4673
2021
Q3
$716K Sell
28,233
-50,378
-64% -$1.22M ﹤0.01% 5355
2021
Q2
$1.77M Buy
78,611
+29,344
+60% +$601K ﹤0.01% 4434
2021
Q1
$973K Buy
49,267
+45,741
+1,297% +$1.15M ﹤0.01% 4849
2020
Q4
$93K Sell
3,526
-179
-5% -$6.66K ﹤0.01% 6023
2020
Q3
$183K Buy
3,705
+3,505
+1,753% +$140K ﹤0.01% 5353
2020
Q2
$6K Buy
+200
New +$6.43K ﹤0.01% 6537

Other funds holding PCVX